October 03, 2014
Philanthropic support has enabled the UAB Department of Neurology to make huge strides in knowledge of diseases such as Parkinson’s.
September 04, 2014
The eye is a window to the brain; scientists discover early signs of dementia in changes to neurons in the eye’s retina.
June 19, 2014
UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
Research in personalized medicine, health informatics and genomic medicine spans disciplines and will impact the treatment of many diseases.
A new UAB clinic can predict risk for developing Alzheimer’s disease and offer strategies to reduce that risk.
As part of its ongoing Science, Communication and Innovation talks, Lucas Pozzo-Miller will speak about Rett syndrome.
A new NIH grant could allow researchers to better predict risk factors for patients using blood-thinners by examining the influence of genes, lifestyle, clinical factors and environment.
Parkinson’s disease awareness is highlighted with official recognition from Alabama and the city of Birmingham in April.
April 10, 2014
The University of Alabama System Board of Trustees approved two endowed positions, an endowed lectureship and three emeritus promotions.
Cash awards were given for best oral and poster presentations at the 9th Annual Health Disparities Research Symposium.
March 12, 2014
February 25, 2014
UAB has teamed with the Michael J. Fox Foundation to look for genetic biomarkers for Parkinson’s disease.
February 12, 2014
The University of Alabama System Board of Trustees approve new endowments, promotions and programs during its Feb. 7 meeting.
January 27, 2014
Neuroscience Café serves healthy portions of fascinating topics in the field of neuroscience at 6:30 p.m. on the third Monday of every month.
Published in Student Experience
Researchers at UAB show that high-intensity strength training improves mobility, mood and overall quality of life for Parkinson’s patients.
January 22, 2014
CNET promotes the discovery of novel treatments for neurodegenerative disorders, teaches scientists and clinicians about these diseases, and facilitates the application of these discoveries to the clinical care of patients.